Compare Bio Protocol (BIO) vs Obol (OBOL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Obol — how do they compare? Bio Protocol trades at Rp435.69 (market cap Rp986,63M, Rp162,5M 24h volume), while Obol trades at Rp157.55 (market cap Rp30,1M, Rp51,72M 24h volume). The key difference: Bio Protocol is far larger — about 32.8× Obol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 161,3M / 500M OBOL (33%) for Obol. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Obol for 16 Days on average.
| BIO | OBOL | |
|---|---|---|
Market Cap | Rp986,63M | Rp30,1M |
Volume (24h) | Rp162,5M | Rp51,72M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 161,3M / 500M OBOL (33%) |
Typical Hold Time | 18 Days | 16 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
OBOL is a low-market-cap cryptocurrency with a market cap of Rp30.1 million and a circulating supply of 161.3 million tokens out of a maximum 500 million, indicating a 33% circulation rate. The asset shows limited trading activity with an average hold time of 16 days. No recent price or volume data is available, suggesting low liquidity. There are no major protocol updates or ecosystem developments reported recently.
The outlook for OBOL is highly speculative due to its small market size and lack of recent data. Key opportunities include potential growth if the project gains adoption, but major risks involve extreme volatility, low liquidity, and minimal market presence. Investors should exercise caution and conduct thorough research before considering this asset.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Obol
Obol develops vital technologies that enhance Ethereum's decentralization and security, currently protecting billions in staked ETH. Its Distributed Validators (DVs) offer better uptime, lower risk, and improved performance compared to traditional staking. Using the middleware Charon, DVs enable Ethereum validators to function across multiple operators and machines, featuring threshold signing and distributed key generation for added resilience. The Obol Collective, powered by the OBOL Token, includes the largest decentralized operator ecosystem with major players like Lido and Blockdaemon. The Obol Stack simplifies the deployment of Ethereum nodes and other decentralized infrastructures, advancing the Ethereum economy.
Read more on OBOL →
